NEW YORK (GenomeWeb News) - The Canadian company BiOasis Technologies has appointed Leigh Anderson to its scientific advisory board. Anderson is founder and CEO of the Plasma Proteome Institute and he served as CSO at Large Scale Biology Corporation. He serves on the advisory board of the UVic-Genome BC Proteomics Center and Better Biomarkers of Acute and Chronic Allograft Rejection, a Genome Canada Initiative for Human Health program.
Cold Spring Harbor Laboratory President Bruce Stillman has been elected to the American Academy of Arts and Sciences. Stillman has been director of the CSHL Cancer Center since 1994 and he has been president since 2003.
California Institute of Technology professor Frances Arnold has been elected to the National Academy of Sciences. Arnold’s research has focused on protein engineering for commercial applications. According to CalTech, Arnold is the only woman so far to have been elected to three branches of the National Academies.
GeneNews has named Harry Glorikian and Fran Tuttle to its board of directors. Glorikian is managing partner of Scientia Advisors and he previously was a senior manager at Applied Biosystems and a sales manager for Signet Laboratories. Tuttle currently is president and CEO of HX Diagnostics and previously served as president and CEO of Protedyne and was a senior VP at Bayer Diagnostics.
Donal Quinn has been promoted to head of the Diagnostics division at Siemens Healthcare. Quinn is leaving his position as executive VP and chief customer officer and will succeed Jim Reid-Anderson, who now is CEO of the sector.
Quinn was controller for Abbott Laboratories, Ireland, and he was group president of biology and later president of Europe, Middle East, and Africa at Dade Behring.
Sigma-Aldrich has re-elected several members of its board of directors, including CEO Jai Nagarkatti, Chariman David Harvey, Lee McCollum, Avi Nash, Steven Paul, Pedro Reinhard, Timothy Sear, Dean Spatz, and Barrett Toan. The company also elected Rebecca Bergman to the board, and William O’Neill retired after being a director for 21 years.
Medgenics has appointed Ehud Shoshani to the post of VP of clinical affairs. Shoshani formerly was CEO, medical director, and head of clinical operations at Quintiles.
Luminex has hired Mimi Torrington as director of investor relations, a company official said during the firm’s first-quarter conference call this week.
David Norwood, Riccardo Pigliucci, Trevor Nicholls, and Hagan Bayley have been appointed to the board of nanopore sequencing company Oxford Nanolabs, GenomeWeb Daily News sister publication In Sequence reported this week.
Bayley is a company founder and a professor of chemistry at the University of Oxford. Norwood, who chairs the board, is director of special projects at IP Group, one of the company’s investors. Pigliucci is a former president and chief operating officer of Perkin-Elmer, which is now Applera. Nicholls is a former chief commercial officer of Affymetrix and the former commercial director of the life-science business of Amersham International, now part of GE Healthcare.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in PEOPLE, a weekly roundup of industry comings and goings.